SG11201408194SA - Method for producing haemophilus influenzae type b antigens - Google Patents

Method for producing haemophilus influenzae type b antigens

Info

Publication number
SG11201408194SA
SG11201408194SA SG11201408194SA SG11201408194SA SG11201408194SA SG 11201408194S A SG11201408194S A SG 11201408194SA SG 11201408194S A SG11201408194S A SG 11201408194SA SG 11201408194S A SG11201408194S A SG 11201408194SA SG 11201408194S A SG11201408194S A SG 11201408194SA
Authority
SG
Singapore
Prior art keywords
culture
des
internationale
influenzae type
pour
Prior art date
Application number
SG11201408194SA
Other languages
English (en)
Inventor
Hir Jérome Le
Pascal Loubiere
Fabien Barbirato
Nicholas Lindley
Original Assignee
Sanofi Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur filed Critical Sanofi Pasteur
Publication of SG11201408194SA publication Critical patent/SG11201408194SA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11201408194SA 2012-07-02 2013-07-02 Method for producing haemophilus influenzae type b antigens SG11201408194SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1256329A FR2992656B1 (fr) 2012-07-02 2012-07-02 Procede de production d'antigenes haemophilus influenzae type b
PCT/FR2013/051549 WO2014006318A1 (fr) 2012-07-02 2013-07-02 Procédé de production d'antigènes haemophilus influenzae type b

Publications (1)

Publication Number Publication Date
SG11201408194SA true SG11201408194SA (en) 2015-01-29

Family

ID=47666183

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201408194SA SG11201408194SA (en) 2012-07-02 2013-07-02 Method for producing haemophilus influenzae type b antigens

Country Status (33)

Country Link
US (2) US9556464B2 (ko)
EP (1) EP2885397B1 (ko)
JP (1) JP6347778B2 (ko)
KR (1) KR102051482B1 (ko)
CN (1) CN104583390B (ko)
AU (1) AU2013285306B2 (ko)
BR (1) BR112014033082B1 (ko)
CA (1) CA2878053C (ko)
CR (1) CR20140559A (ko)
CY (1) CY1120465T1 (ko)
DK (1) DK2885397T3 (ko)
ES (1) ES2681993T3 (ko)
FR (1) FR2992656B1 (ko)
GE (1) GEP201706788B (ko)
HK (1) HK1208493A1 (ko)
HR (1) HRP20181206T1 (ko)
HU (1) HUE038865T2 (ko)
IL (1) IL236208A0 (ko)
LT (1) LT2885397T (ko)
MX (1) MX358953B (ko)
NZ (1) NZ702471A (ko)
PE (1) PE20150192A1 (ko)
PH (1) PH12014502730B1 (ko)
PL (1) PL2885397T3 (ko)
PT (1) PT2885397T (ko)
RS (1) RS57495B1 (ko)
RU (1) RU2644246C2 (ko)
SG (1) SG11201408194SA (ko)
SI (1) SI2885397T1 (ko)
TR (1) TR201810678T4 (ko)
UA (1) UA115787C2 (ko)
WO (1) WO2014006318A1 (ko)
ZA (2) ZA201500014B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2624014C1 (ru) * 2016-04-08 2017-06-30 Федеральное государственное унитарное предприятие "Санкт-Петербургский научно-исследовательский институт вакцин и сывороток и предприятие по производству бактерийных препаратов" Федерального медико-биологического агентства России (ФГУП СПбНИИВС ФМБА России) Штамм haemophilus influenzae spb тип в - высокоактивный продуцент капсульного полисахарида полирибозилрибитолфосфата
US11027005B2 (en) 2016-10-20 2021-06-08 Km Biologics Co., Ltd. Method for producing Hib conjugate vaccine using PRP with lowered molecular weight
UA127497C2 (uk) * 2017-04-22 2023-09-13 Байолоджикал Е Лімітед СПОСІБ ВЕЛИКОМАСШТАБНОГО ВИРОБНИЦТВА CRM<sub>197</sub>
RU2704452C1 (ru) * 2019-04-22 2019-10-28 Федеральное государственное унитарное предприятие "Санкт-Петербургский научно-исследовательский институт вакцин и сывороток и предприятие по производству бактерийных препаратов" Федерального медико-биологического агентства Способ получения вакцины гемофильной тип b конъюгированной
CN109975559B (zh) * 2019-04-29 2023-07-11 厦门稀土材料研究所 一种时间分辨荧光定量检测25羟基维生素d的试剂盒及方法
CN111000994A (zh) * 2019-12-26 2020-04-14 北京科兴中维生物技术有限公司 一种液体疫苗组合物及其制备方法与应用
CN112212779B (zh) * 2020-09-04 2022-05-17 厦门大学 一种水凝胶柔性应变传感器的制备方法
KR20220072781A (ko) * 2020-11-25 2022-06-02 주식회사 엘지화학 헤모필루스 인플루엔자 타입 b의 PRP 항원 정제 공정의 품질 평가 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03183416A (ja) * 1989-12-12 1991-08-09 Shozo Oyama 菌根菌を培養する方法、およびその子実体を取得する方法
FR2791895B1 (fr) * 1999-03-23 2001-06-15 Pasteur Merieux Serums Vacc Utilisation de trehalose pour stabiliser un vaccin liquide
RU2258737C2 (ru) * 2003-09-01 2005-08-20 Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова РАМН Питательная среда для культивирования бактерий haemophilus influenzae типа b
FR2914302A1 (fr) * 2007-03-30 2008-10-03 Sanofi Pasteur Sa Procede de preparation de derives de porphyrine, telle que la protoporphyrine (ix) et intermediaire de synthese
FR2918671B1 (fr) * 2007-07-10 2010-10-15 Sanofi Pasteur Milieu de culture d'haemophilus influenzae type b.
GB0818453D0 (en) * 2008-10-08 2008-11-12 Novartis Ag Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
PE20100366A1 (es) * 2008-10-24 2010-05-21 Panacea Biotec Ltd Novedosas composiciones de vacuna con tos ferina acelular asi como el metodo para su elaboracion
TW201129698A (en) * 2009-12-10 2011-09-01 Jgc Corp New cell culture method

Also Published As

Publication number Publication date
MX2014014607A (es) 2015-02-12
RU2644246C2 (ru) 2018-02-08
CR20140559A (es) 2015-04-06
DK2885397T3 (en) 2018-08-06
UA115787C2 (uk) 2017-12-26
US20150167036A1 (en) 2015-06-18
IL236208A0 (en) 2015-01-29
BR112014033082B1 (pt) 2022-02-15
NZ702471A (en) 2017-08-25
RS57495B1 (sr) 2018-10-31
JP6347778B2 (ja) 2018-06-27
TR201810678T4 (tr) 2018-08-27
GEP201706788B (en) 2017-12-11
WO2014006318A1 (fr) 2014-01-09
KR20150036311A (ko) 2015-04-07
PH12014502730A1 (en) 2015-02-02
CN104583390A (zh) 2015-04-29
BR112014033082A2 (pt) 2017-06-27
HRP20181206T1 (hr) 2018-10-05
HK1208493A1 (en) 2016-03-04
CA2878053C (fr) 2021-07-06
EP2885397A1 (fr) 2015-06-24
SI2885397T1 (sl) 2018-09-28
PT2885397T (pt) 2018-07-27
ZA201500028B (en) 2016-10-26
ZA201500014B (en) 2016-10-26
KR102051482B1 (ko) 2019-12-03
CA2878053A1 (fr) 2014-01-09
EP2885397B1 (fr) 2018-05-30
AU2013285306A1 (en) 2015-01-15
AU2013285306B2 (en) 2018-10-04
CY1120465T1 (el) 2019-07-10
US10144940B2 (en) 2018-12-04
RU2015103140A (ru) 2016-08-27
US20170211111A1 (en) 2017-07-27
ES2681993T3 (es) 2018-09-17
CN104583390B (zh) 2018-07-10
US9556464B2 (en) 2017-01-31
PH12014502730B1 (en) 2015-02-02
FR2992656A1 (fr) 2014-01-03
HUE038865T2 (hu) 2018-12-28
LT2885397T (lt) 2018-08-27
PE20150192A1 (es) 2015-02-27
JP2015522272A (ja) 2015-08-06
MX358953B (es) 2018-09-10
PL2885397T3 (pl) 2018-10-31
FR2992656B1 (fr) 2016-10-07

Similar Documents

Publication Publication Date Title
SG11201408194SA (en) Method for producing haemophilus influenzae type b antigens
SG11201406738YA (en) Protective cap for a pressurised fluid cylinder valve and production method thereof
SG11201909184RA (en) Cultured meat-containing hybrid food
SG11201806630QA (en) Self-propelled personal transportation device
SG11201804672QA (en) Systems and methods for production of low oxygen content silicon
SG11201809040YA (en) Hybrid aerosol-generating element and method for manufacturing a hybrid aerosol-generating element
SG11201805217XA (en) Compositions and methods for the treatment of hemoglobinopathies
SG11201808721YA (en) Cell-free production of ribonucleic acid
SG11201805044WA (en) Compounds useful as kinase inhibitors
SG11201807114TA (en) Colony forming medium and use thereof
SG11201804373VA (en) Compositions and methods for immunooncology
SG11201404936YA (en) Channel plate heat transfer system
SG11201408681RA (en) Portion capsule comprising a plastic film provided with a machine-detectable identification
SG11201408263QA (en) Laver-snack made of laver and cereal sheets and process of producing the same
SG11201805162VA (en) Plasmid constructs for heterologous protein expression and methods of use
SG11201407852PA (en) Beauty tool
SG11201407902YA (en) Methods and compositions for biomethane production.
SG11201407819UA (en) Improved methods of cell culture for adoptive cell therapy
SG11201406828UA (en) Cartridge for a stereolithographic machine, stereolithographic machine comprising said cartridge and method of manufacturing said cartridge
SG11201804117XA (en) Neural cell extracellular vessicles
SG11201808710UA (en) Novel immunogenic cd1d binding peptides
SG11201808705XA (en) Particle manipulation
SG11201804888WA (en) Velocity model update with an inversion gradient
SG11201408297XA (en) Porous graphene oxide materials
SG11201804770QA (en) Method and arrangement for recovery of salt